A, PSMA-targeted infection. LNCaP, PC-3-PSMA (+) and PC-3-PSMA (-) cells were infected with Ad5Track-Luc-Saupw-1 (selected virus) or Ad5Track-Luc-Saurabh (parental virus), MOI =1. Virus infection was quantified by firefly luciferase activity (Relative Light Units, RLU, per mg protein). Columns, averages (n=3); Bars, SE. B, Infection is mediated by PSMA-binding peptide. LNCaP cells were pre-incubated with serially diluted PSMA-binding peptide or an unrelated control peptide for 30 min, followed by infection with Ad5Track-Luc-Saupw-1 or Ad5Track-Luc-WtFiber. Infection was quantified by luciferase activity, relative to non-inhibited wild-type fiber. Bars represent mean±SE infection of three replicates. C, Adenoviral infection following systemic injection. Mice bearing LNCaP tumors were intravenously injected with Ad5Track-Luc-Saupw-1 or Ad5Track-Luc-WtFiber (1 × 109 IU). After four days, viral infection was quantified by ex vivo luciferase activity of tissue lysates. Columns, averages (n=3); Bars, SE. D, Relative infection. Tumor to tissue luciferase ratios for each virus four days after virus administration. Statistical evaluation: *, P<0.05, **, P<0.01, ***, P < 0.001 (Student's t-test).